v3.26.1
Consolidated Statements of Changes in Deficit
Ordinary shares
Class A
CNY (¥)
shares
Ordinary shares
Class A
USD ($)
shares
Ordinary shares
Class B
CNY (¥)
shares
Ordinary shares
Class B
USD ($)
shares
Subscription receivable
CNY (¥)
Subscription receivable
USD ($)
Additional paid-in capital
CNY (¥)
Additional paid-in capital
USD ($)
Accumulated deficit
CNY (¥)
Accumulated deficit
USD ($)
Accumulated other comprehensive loss
CNY (¥)
Accumulated other comprehensive loss
USD ($)
Total Pomdoctor Limited’s shareholders’ deficit
CNY (¥)
Total Pomdoctor Limited’s shareholders’ deficit
USD ($)
Noncontrolling interests
CNY (¥)
Noncontrolling interests
USD ($)
CNY (¥)
USD ($)
Balance (in Dollars) ¥ 2,988 [1]   ¥ 1,408 [1]   ¥ (1,608)     ¥ (1,974,667,719)     ¥ (1,974,664,931)   ¥ (8,769)   ¥ (1,974,673,700)  
Balance (in Shares) | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Balance at Dec. 31, 2022 ¥ 2,988 [1]   ¥ 1,408 [1]   (1,608)     (1,974,667,719)     (1,974,664,931)   (8,769)   (1,974,673,700)  
Balance (in Shares) at Dec. 31, 2022 | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Net income (loss) [1]   [1]         (36,950,478)     (36,950,478)   1,057   (36,949,421)  
Other comprehensive loss                                  
Accretion on convertible redeemable preferred shares to redemption value [1]   [1]         (108,440,354)     (108,440,354)     (108,440,354)  
Balance at Dec. 31, 2023 ¥ 2,988 [1]   ¥ 1,408 [1]   (1,608)     (2,120,058,551)     (2,120,055,763)   (7,712)   (2,120,063,475)  
Balance (in Shares) at Dec. 31, 2023 | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Balance (in Dollars) ¥ 2,988 [1]   ¥ 1,408 [1]   (1,608)     (2,120,058,551)     (2,120,055,763)   (7,712)   (2,120,063,475)  
Balance (in Shares) | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Net income (loss) [1]   [1]         (37,391,312)     (37,391,312)   25,878   (37,365,434)  
Other comprehensive loss [1]   [1]           (5,231)   (5,231)       (5,231)  
Accretion on convertible redeemable preferred shares to redemption value [1]   [1]         (105,969,614)     (105,969,614)     (105,969,614)  
Balance at Dec. 31, 2024 ¥ 2,988 [1]   ¥ 1,408 [1]   (1,608)     (2,263,419,477)   (5,231)   (2,263,421,920)   18,166   (2,263,403,754)  
Balance (in Shares) at Dec. 31, 2024 | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Balance (in Dollars) ¥ 2,988 [1]   ¥ 1,408 [1]   (1,608)     (2,263,419,477)   (5,231)   (2,263,421,920)   18,166   (2,263,403,754)  
Balance (in Shares) | shares [1] 4,268,156 4,268,156 2,042,042 2,042,042                            
Net income (loss) [1]   [1]         (130,930,401)     (130,930,401)   (1,520)   (130,931,921) $ (18,723,015)
Issuance of Class A ordinary shares upon initial public offering (“IPO”), net of offering cost ¥ 683 [1]   [1]       134,802,490         134,803,173     134,803,173  
Issuance of Class A ordinary shares upon initial public offering (“IPO”), net of offering cost (in Shares) | shares [1] 958,334 958,334                                
Conversion of redeemable preferred shares to Class A ordinary shares ¥ 8,979 [1]   [1]       1,668,965,268         1,668,974,247     1,668,974,247  
Conversion of redeemable preferred shares to Class A ordinary shares (in Shares) | shares [1] 12,597,228 12,597,228                                
Conversion of redeemable non-controlling interest into ordinary shares of the VIE [1]   [1]       203,739,302         203,739,302   (27,342,041)   176,397,261  
Issuance of Class A ordinary shares from share-based compensation ¥ 2,347 [1]   [1]   (578)   16,258,509         16,260,278     16,260,278  
Issuance of Class A ordinary shares from share-based compensation (in Shares) | shares [1] 3,317,204 3,317,204                                
Other comprehensive loss [1]   [1]           (1,747,229)   (1,747,229)       (1,747,229) (249,850)
Accretion on convertible redeemable preferred shares to redemption value [1]   [1]         (81,648,716)     (81,648,716)     (81,648,716)  
Balance at Dec. 31, 2025 ¥ 14,997 [1] $ 2,145 [1] ¥ 1,408 [1] $ 201 [1] (2,186) $ (313) 2,023,765,569 $ 289,394,627 (2,475,998,594) $ (354,063,090) (1,752,460) $ (250,598) (453,971,266) $ (64,917,028) (27,325,395) $ (3,907,480) (481,296,661) (68,824,508)
Balance (in Shares) at Dec. 31, 2025 | shares [1] 21,140,922 21,140,922 2,042,042 2,042,042                            
Balance (in Dollars) ¥ 14,997 [1] $ 2,145 [1] ¥ 1,408 [1] $ 201 [1] ¥ (2,186) $ (313) ¥ 2,023,765,569 $ 289,394,627 ¥ (2,475,998,594) $ (354,063,090) ¥ (1,752,460) $ (250,598) ¥ (453,971,266) $ (64,917,028) ¥ (27,325,395) $ (3,907,480) ¥ (481,296,661) $ (68,824,508)
Balance (in Shares) | shares [1] 21,140,922 21,140,922 2,042,042 2,042,042                            
[1] Ordinary shares and share data have been retroactively restated to give effect to the nominal share issuance for the Reorganization completed on August 8, 2024 (Note 1).